A 24 Month, multi-center, open-lable randomized, control

Project: Research project

Project Details

Description

A 24 Month, multi-center, open-lable randomized, controlled study to evaluate the efficacy and safety of concentration-controlled everolimus to eliminate or reduce racrolimus compared to tacrolimus in de novo liver transplant recipients.
StatusFinished
Effective start/end date7/2/091/4/12

Funding

  • Novartis Pharma AG

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.